J&J: 41-fold intensive boost vs. omicron in mix-and-match st...
J&J: 41-fold intensive boost vs. omicron in mix-and-match study.
Johnson & Johnson: A mixed vaccine study found that antibody levels against the Omicron variant increased 41 times.
Johnson & Johnson: A mixed vaccine study found that antibody levels against the Omicron variant increased 41 times.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Twitter@Sino_Market | Realtime Chinese market info provider.
9212Followers
4Following
8757Visitors
Follow